OP-181 Evaluation of Serum Levels of Pentraxin 3 and Oxidative Stress in Patients with İron Deficiency Anemia Having Normal Left Ventricular Systolic Functions




Objective


Oxidative stress is associated with cardiovascular diseases and pentraxin 3 (PTX3) is independently associated with the risk of developing vascular events. PTX3 deficiency is associated with increased inflammation, cardiac damage, and atherosclerosis. The present trial was designed to investigate the effects of iron deficiency anemia (IDA) on plasma oxidant/antioxidant balance and to determine the relation between the PTX3 levels and the oxidative stress parameters in patients with IDA.




Methods


A total of 72 individuals, including 37 patients with IDA and 35 healthy controls were enrolled in the study. Oxidative and anti-oxidative status was evaluated by measuring the total oxidative stress (TOS), the oxidative stress index (OSI) and total anti-oxidant status (TAS). Serum PTX3 level was measured by enzyme immunoassay using a quantitative kit.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. OP-001 An Under-estimated Complication ff Atrial Fibrillation Ablation: Gastroparesis
  2. OP-038 Reduction of Eosinophil Percentage may Predict the Mortality from Acute Coronary Syndromes
  3. OP-065 Increased Platelet-to-Lymphocyte Ratio is Related to Slow Coronary Flow
  4. OP-100 Pulmonary Function after Transcatheter Aortic Valve Implantation in Patients with High Risk Aortic Stenosis

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 30, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-181 Evaluation of Serum Levels of Pentraxin 3 and Oxidative Stress in Patients with İron Deficiency Anemia Having Normal Left Ventricular Systolic Functions

Full access? Get Clinical Tree
Get Clinical Tree app for offline access